Clinical features and prognostic factors of early breast cancer at a major cancer center in North India

Abstract

BACKGROUND: Data on the clinical profile of early breast cancer (EBC) from India is scant. Due to differences in

Complications of Axillary Lymph Node Dissection in Treatment of Early Breast Cancer: A Comparison of MRM and BCS

“…Various Indian studies have shown receptor positivity as 43.9%, 50.5% and 53% [31,42,43]. In this study also 57% patients were estrogen receptor positive and 53% were positive for progesterone receptor.…”

“…In a study by Raina et al on EBC patients, 53.13% were node negative, 32.61% had 1-3 lymph nodes positive and 14.25% had >-4 lymph nodes positive [31]. In our study 51% patients were node negative, 32% had 1-3 lymph nodes positive and 17% had 4 or more lymph nodes positive for metastasis.…”

“…In a study at AIIMS 16% patients had stage I and 74% had stage II disease [31], whereas in developed countries 50-60% patients present with stage I disease [34][35][36]. In this study also on pathological staging 14% patients were in stage I, 69% were in stage II and 17% were in stage III.…”

“…Median age of the patients in India is 47 years [31]. 73% of the white female patients are post menopausal and only 35%, 49% and 52% of Asians, blacks and mixed race respectively are post menopausal [32].…”

“…In this study 53% patients were post menopausal. Lump is the chief complaint in 96.5% and pain in 15.8% [31]. Approximately 40-50% of breast cancers are located in upper outer quadrant, one quarter in juxta areolar area and remainder randomly distributed throughout medial and lower outer quadrant of the breast [33].…”